In the ever-evolving landscape of pharmaceuticals, one of the more nuanced and strategic decisions a brand company can make is whether to launch an Authorized Generic (AGx) product. I’ve been fortunate to work closely with clients navigating this decision, and…
From seamless sales operations to savvy social media usage, innovative marketing campaigns to effective go-to-market structures, some companies just always seem “one step ahead.” How do they do it? What competitive advantages do these organizations maintain — and are they…
As global trade dynamics shift yet again, the pharmaceutical industry is bracing for impact. Recent tariff developments—particularly the reintroduction of sweeping U.S. import duties—are prompting executives across healthcare and life sciences to revisit their sourcing strategies and cost structures. But…
Working in the pharmaceutical space, I’ve witnessed firsthand how biosimilars have shifted from a theoretical disruption to a real force reshaping market dynamics. Whether you’re on the innovator side trying to protect share or part of a biosimilar team plotting…
When I first started working in the rare disease and gene therapy space, I thought the science would be the hardest part to wrap my head around. And don’t get me wrong—it’s complex. But what I didn’t fully appreciate at…
I’ll admit it—there was a time when neuroscience felt like a graveyard of pharma ambitions. I remember the wave of program terminations, the clinical failures, and the retreat from Alzheimer’s and Parkinson’s pipelines that felt almost industry wide. For a…
Picture this: You’re in a high-stakes chess match. The room is silent. The tension is thick. Every move counts. But instead of thinking ahead, you’re fixated on where your opponent used to be five turns ago. You can guess what…
Competitive intelligence in biotech and pharma isn’t just about tracking pipeline developments—it’s a high-stakes game where missing a key move can cost billions. Yet, time and again, companies fail to anticipate threats because they focus only on obvious competitors, outdated…
A Preview of My Upcoming Talk: Presenting Pricing Insights That Resonate with Leaders Pricing strategies often rely on robust data—carefully researched, meticulously analyzed, and expertly compiled. Yet, even the most data-driven pricing recommendations can be met with hesitation, skepticism, or…
Get in touch with our market intelligence company today
to start planning for the future of your organization.
